Navigation Links
Blazing Statistics: Burn Victims in USA Are Old and Poor

The HHS' Agency for Healthcare Research and Quality has reported that more than $726 million , roughly 45% of the changes to treat burn victims is billed to Medicare or Medicaid, government programs intended for the senior// citizens and the under privileged.

According to statistics, the average charge is $59,600 for Medicare patients and $47,400 for Medicaid patients; the average charge for burn victims with private insurance is $41,400; and for uninsured burn victims, the average charge is $34,900.

1. Private insurers are billed for 29% of 33,000 hospitalizations of burn victims with 11 percent charges to uninsured burn victims.

2. Nearly 3.7 percent of all burn victims succumb to the burns, while in the hospital, with death rate climbing to 12% among the 65 or more age group.

3. Men, more prone to burn accidents, as two of every three hospitalized burn victims are men.

The statistics reported are for 2003, which excludes Physician’s fees.

Further Details are available at http://hcup.ahrq.gov/HCUPnet.asp


'"/>




Page: 1

Related medicine news :

1. Snail venom Found To Ease Pain In Cancer Victims
2. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
3. Men Victims Of Breast Cancer?
4. Need for Psychotherapy for Delhi Blast Victims
5. Students Involved In Bullying And Victims Were Equally Stressed
6. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
7. Russian Miss HIV Positive Says Victims Are Treated Like Prostitutes
8. Doctors Resign from Hospital for Bhopal Gas Victims
9. UN Fears Earthquake Victims Could Turn To Drugs
10. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
11. Chinese Herbs Do Not Increase Survival Rate Of SARS Victims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: